Loading clinical trials...
Loading clinical trials...
A Single-center, Randomized, Double-blind, Controlled Study Lasting for 56 Days to Evaluate the Safety and Efficacy of LA ROCHE-POSAY CICAPLAST BAUME B5+ in Individuals With Rosacea Accompanied by Sensitive Skin
Conditions
Interventions
CICAPLAST BAUME B5+
Standard cream
Locations
1
China
Beijing Sino-German Union Cosmetic Institute Co., Ltd.
Beijing, China
Start Date
June 10, 2025
Primary Completion Date
August 10, 2025
Completion Date
August 10, 2025
Last Updated
August 6, 2025
Lead Sponsor
Beijing Sino-German Union Cosmetic Institute Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions